Zhang Jingbo
Department of Radiology, Memorial Sloan-Kettering Cancer Center, Cornell Weill Medical College, New York, New York 10016, USA.
Curr Opin Urol. 2008 Jan;18(1):111-5. doi: 10.1097/MOU.0b013e3282f13a9b.
The aim of this article is to discuss the expanded role of imaging and imaging-guided biopsy in the management of renal tumors.
Certain features on cross-sectional imaging aid in preoperative differentiation of renal parenchymal tumors. Volumetric measurement on imaging has demonstrated variable growth rate among renal tumors. Radioisotope labeled chimeric G250, a monoclonal antibody to carbonic anhydrase IX antigen, has shown the potential to target clear cell renal carcinoma with high sensitivity and specificity. With advances in technology, imaging-guided biopsy has shown higher accuracy and diagnostic rate than the past in the preoperative diagnosis of renal tumors.
Greater understanding of the imaging features of specific kinds of renal masses and more accurate imaging-guided biopsy are important advances in the management of renal tumors.
